Earnings Ahead

CYTK - Cytokinetics Inc.

33.75 0.81 2.46

Cytokinetics Inc.

Cytokinetics Inc.

About

Profile


Headquarters


Intraday

High
-
Low
-

52-week

High
-
Low
-

CYTK



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Cytokinetics GAAP EPS of -$1.38 misses by $0.39, revenue of $1.67M misses by $11.59M
  • Cytokinetics Q4 2023 Earnings Preview
  • Cytokinetics seesaws as CEO says not conducting a sales process
  • Cytokinetics weakness a buying opportunity, Truist says
  • Biggest stock movers today: Nvidia, Air Products and Chemicals, Estee Lauder, 4D Molecular Therapeutics, and more
  • Cytokinetics announces resignation of Ching W. Jaw as chief financial officer
  • UBS cuts Cytokinetics to neutral, sees takeout valuation at $105
  • Amgen may be evaluating Cytokinetics bid; CYTK wants $130-$145 a share - report (update)
  • Cytokinetics plunges amid no deal announcement, Novartis backing away (update)
  • Novartis said to have backed away from a deal for Cytokinetics
  • Cytokinetics drops as Novartis CEO says the company is focused on bolt-on deals
  • Cytokinetics soars on report Novartis in advanced talks to purchase
  • Cytokinetics falls amid no sale announcement
  • Morgan Stanley cuts Cytokinetics to equal weight but raises price target
  • Catalyst Watch: CES lights up tech, retail's ICR conference and bank earnings blitz
  • Needham says Cytokinetics' appeal as M&A target enhanced by HCM data
  • Biggest stock movers today: Tesla, crypto-related names, Cytokinetics, Masimo and more
  • Cytokinetics gains on positive Phase 3 data for heart disease therapy (update)
  • Cytokinetics may be worth $90+ a share in potential deal amid Phase 3 data - UFP
  • Cytokinetics soars amid report of Novartis, AstraZeneca takeover interest

Earnings History

Date EPS / Forecast Revenue / Forecast
February 24, 2022 -0.36 / -0.8711 55.6M / 5.8M Beat!
November 3, 2021 -0.95 / -0.776 5.44M / 5.98M
August 5, 2021 -0.86 / -0.66 2.84M / 5.52M
May 6, 2021 -0.66 / -0.5838 6.55M / 6.57M
February 25, 2021 -0.62 / -0.4343 6.72M / 23.76M
November 4, 2020 -0.05 / -0.3375 41.69M / 4.02M Beat!
August 6, 2020 -0.68 / -0.57 3.59M / 4.07M
May 6, 2020 -0.66 / -0.5 3.83M / 5.01M
March 3, 2020 -0.52 / -0.44 5.21M / 7.2M
February 19, 2020 - / -0.44 - / 7.2M
October 31, 2019 -0.5 / -0.49 6.06M / 7.52M
August 8, 2019 -0.56 / -0.5 7.14M / 6.99M Beat!
May 9, 2019 -0.54 / -0.47 8.46M / 6.86M Beat!
February 21, 2019 -0.48 / -0.51 9.38M / 3.94M Beat!
November 1, 2018 -0.4 / -0.51 10.64M / 3.15M Beat!
July 26, 2018 -0.51 / -0.51 6.22M / 5.19M Beat!
February 14, 2018 - / -0.7 - / 6.32M
October 26, 2017 -0.6 / -0.62 6.18M / 6.47M
August 2, 2017 -0.6 / -0.63 3.05M / 8.33M
April 27, 2017 -0.62 / -0.66 4.15M / - Beat!
February 16, 2017 0.16 / -0.17 33.14M / 9.09M Beat!
October 27, 2016 0.16 / -0.38 59.05M / 7.04M Beat!
Date Price Open High Low Vol Change ER
Oct 9, 2023 31.7 30.67
31.75
30.13
1.4M 3.59%
Oct 6, 2023 30.6 27.34
31.36
26.83
2.6M 11.39%
Oct 5, 2023 27.47 26.95
27.7
26.55
802K 1.55%
Oct 4, 2023 27.05 26.85
27.33
25.98
1.1M 0.63%
Oct 3, 2023 26.88 27.91
28.17
26.57
1.2M -3.59%
 
Oct 2, 2023 27.88 29.36
29.4
27.56
1.6M -5.36%
Sep 29, 2023 29.46 31.01
31.09
29.25
1.7M -4.35%
Sep 28, 2023 30.8 29.81
31.72
28.96
1.6M 2.94%
Sep 27, 2023 29.92 30.01
30.55
29.71
706K -0.27%
Sep 26, 2023 30 30.08
30.66
29.79
1.0M 0.07%
Sep 25, 2023 29.98 30.79
31.02
29.9
609K -3.13%
Sep 22, 2023 30.95 31.4
31.54
30.84
408K -0.93%
Sep 21, 2023 31.24 31.44
31.9
30.59
1.0M -2.28%
Sep 20, 2023 31.97 32.76
33.03
31.96
849K -2.92%
Sep 19, 2023 32.93 33.87
34.38
32.83
775K -2.78%
Sep 18, 2023 33.87 34.12
34.58
33.17
854K -1.05%
Sep 15, 2023 34.23 34.52
34.52
33.65
1.5M 0.06%
Sep 14, 2023 34.21 34.86
35.27
34.16
618K -1.78%
Sep 13, 2023 34.83 35.08
35.21
34.41
735K -0.63%
Sep 12, 2023 35.05 34.73
35.22
34.24
580K 0.92%
Sep 11, 2023 34.73 36.06
36.06
34.66
845K -3.69%
Sep 8, 2023 36.06 36.78
37.1
35.88
700K -1.5%
Sep 7, 2023 36.61 35.67
36.74
35.67
593K 2.23%
Sep 6, 2023 35.81 35.57
36.22
35.49
436K 1.85%
Sep 5, 2023 35.16 35.83
35.87
34.96
585K -2.33%
Sep 1, 2023 36 35.33
36.57
35.3
719K 3.03%
Aug 31, 2023 34.94 35
35.83
34.8
603K -0.8%
Aug 30, 2023 35.22 35.58
35.72
34.92
466K -0.76%
Aug 29, 2023 35.49 35.7
36.08
35.21
373K -1.09%
Aug 28, 2023 35.88 35.06
35.95
34.85
455K 2.93%
Aug 25, 2023 34.86 33.96
35.26
33.68
701K 3.50%
Aug 24, 2023 33.68 32.94
33.77
32.75
557K 1.91%
Aug 23, 2023 33.05 33.58
34.1
32.98
357K -0.93%
Aug 22, 2023 33.36 32.94
33.66
32.26
442K 1.28%
Aug 21, 2023 32.94 32.37
33.32
31.8
554K 1.54%
Aug 18, 2023 32.44 31.66
32.78
31.57
748K 1.76%
Aug 17, 2023 31.88 33.14
33.23
31.81
520K -3.89%
Aug 16, 2023 33.17 32.59
33.69
32.16
785K 1.41%
Aug 15, 2023 32.71 32.32
32.73
31.83
503K 1.90%
Aug 14, 2023 32.1 32.45
32.6
31.63
569K -1.98%
Aug 11, 2023 32.75 32.23
32.76
32.1
338K 0.80%
Aug 10, 2023 32.49 31.7
32.68
31.7
577K 2.17%
Aug 9, 2023 31.8 31.98
32.45
31.63
647K -0.47%
Aug 8, 2023 31.95 31.33
32.14
31
762K 1.91%
Aug 7, 2023 31.35 33.45
33.45
31.05
944K -5.54%
Aug 4, 2023 33.19 31.99
34.97
31.94
1.1M 4.70%
Aug 3, 2023 31.7 31.02
32.27
30.82
1.1M 1.99%
Aug 2, 2023 31.08 32.01
32.44
30.66
817K -4.37%
Aug 1, 2023 32.5 33.09
33.1
32.01
760K -2.55%
Jul 31, 2023 33.35 33
33.43
32.87
691K 0.30%
Jul 28, 2023 33.25 32.28
33.56
32.17
1.3M 3.16%
Jul 27, 2023 32.23 32.68
32.77
31.92
676K -0.52%
Jul 26, 2023 32.4 32.01
32.58
31.81
941K 0.81%
Jul 25, 2023 32.14 32.65
33.15
32.1
884K -2.28%
Jul 24, 2023 32.89 32.76
33.17
32.05
453K 0.52%
Jul 21, 2023 32.72 32.46
33.29
32.26
1.1M 0.99%
Jul 20, 2023 32.4 33.6
33.68
32.39
1.0M -3.63%
Jul 19, 2023 33.62 33.41
34.27
33.33
892K 1.30%
Jul 18, 2023 33.19 33.73
33.89
33.04
704K -1.83%
Jul 17, 2023 33.81 35.18
35.88
33.8
594K 0%